- First international multi-center clinical trial (IMCT) of lemzoparlimab in China
- Second IND approval from China NMPA for lemzoparlimab
PR Newswire
SHANGHAI and GAITHERSBURG, Md., Sept. 21, 2020
PR Newswire
SHANGHAI and GAITHERSBURG, Md., Sept. 21, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey